DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450)
South Korea flag South Korea · Delayed Price · Currency is KRW
19,180
+240 (1.27%)
Jun 12, 2026, 3:30 PM KST

DongKook Pharmaceutical Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
74,51866,02061,21947,17552,89650,345
Depreciation & Amortization
32,57831,71228,46221,09819,18717,358
Loss (Gain) From Sale of Assets
-5,470-5,580-2,154-752.89-609.49-1,042
Asset Writedown & Restructuring Costs
966.191,848----
Loss (Gain) From Sale of Investments
3,7964,723-3,2845,8145,434-1,376
Loss (Gain) on Equity Investments
1,9483,689-2,551896.71-1,122-1,031
Stock-Based Compensation
--115.9-39.2-162.46-297.32-24.01
Provision & Write-off of Bad Debts
2,4172,019-165.02663.85223.25-713.06
Other Operating Activities
8,2098,89819,1862,2215,0343,413
Change in Accounts Receivable
-41,007-43,703-13,751-27,785-10,6643,656
Change in Inventory
-21,755-17,181-17,310-19,223-18,019-24,747
Change in Accounts Payable
25,86525,02912,56128,9544,606-1,349
Change in Unearned Revenue
-41.98-378.01415.170.1--
Change in Other Net Operating Assets
-1,511-8,220-6,498-17,107-15,759163.08
Operating Cash Flow
80,51268,76076,09141,79340,90944,654
Operating Cash Flow Growth
12.19%-9.63%82.07%2.16%-8.39%-24.45%
Capital Expenditures
-51,199-42,715-27,291-34,177-47,914-51,006
Sale of Property, Plant & Equipment
13,33513,4232,9983,57925.3518.27
Cash Acquisitions
---31,703---13,000
Divestitures
--2,5722.03--
Sale (Purchase) of Intangibles
-2,307-3,082-3,937-5,413-4,0581,330
Investment in Securities
-24,947-34,242-5,631-21,13131,83716,655
Other Investing Activities
4,2634,9274,7474,7578,5072,220
Investing Cash Flow
-60,768-61,624-64,864-52,391-12,408-43,530
Short-Term Debt Issued
-29,04139,57132,35812,67030,687
Long-Term Debt Issued
-12,00022,900-35,00022,500
Total Debt Issued
40,10441,04162,47132,35847,67053,187
Short-Term Debt Repaid
--44,741-45,999-21,084-57,836-10,854
Long-Term Debt Repaid
--3,876-27,618-3,049-22,248-3,114
Total Debt Repaid
-57,159-48,617-73,616-24,133-80,084-13,968
Net Debt Issued (Repaid)
-17,054-7,576-11,1468,225-32,41439,219
Issuance of Common Stock
-18,540----
Dividends Paid
-9,244-9,244-8,313-8,051-8,049-8,049
Other Financing Activities
-1,656-2,717-2,846-2,472672.13-1,437
Financing Cash Flow
-27,954-996.97-22,305-2,298-39,79229,733
Foreign Exchange Rate Adjustments
385.57-231.7797.75-245.54-459.6150.51
Net Cash Flow
-7,8245,907-10,281-13,141-11,75030,907
Free Cash Flow
29,31326,04648,8007,616-7,005-6,352
Free Cash Flow Growth
-38.18%-46.63%540.73%---
Free Cash Flow Margin
3.07%2.81%6.01%1.04%-1.06%-1.07%
Free Cash Flow Per Share
652.99581.921090.81170.27-156.64-142.04
Cash Interest Paid
1,7812,1663,3962,921898.192,699
Cash Income Tax Paid
22,20923,07411,33116,61411,67819,975
Levered Free Cash Flow
23,85317,05324,190-15,328-19,169-14,977
Unlevered Free Cash Flow
24,97818,35227,001-11,661-16,469-13,175
Change in Working Capital
-38,450-44,452-24,583-35,160-39,837-22,276